Shows / PETRI DISH PERSPECTIVES
PETRI DISH PERSPECTIVES
Burma | Chicago
Scientist 🥼🧪🔬
Covering biotech, pharma, and healthcare companies shaping the world 🧬🏥🌎
Stream new episodes every THURSDAY!
https://linktr.ee/maneadkhin
#biotech #pharma #healthcare #podcast #petridishperspectives
Episodes
- PETRI DISH PERSPECTIVES
Episode 79: Endeavor Health
Send us Fan Mail In this episode of Petri Dish Perspectives, we explore Endeavor Health, the Chicago-area hospital system most Illinoisans have driven past but…
- PETRI DISH PERSPECTIVES
Episode 78: Dr. Kristin Gleitsman on Using AI to Make Better Drug Development Decisions
Send us Fan Mail After years of building discovery engines inside diagnostics, Kristin Gleitsman has become one of the more skeptical voices in AI and biology…
- PETRI DISH PERSPECTIVES
Episode 77: Revolution Medicines
Send us Fan Mail In this episode of Petri Dish Perspectives, we explore Revolution Medicines, the precision oncology company that spent over a decade trying to…
- PETRI DISH PERSPECTIVES
Episode 76: Dr. Avinash Jayaraman on Why Your Kid's Screen Time Is a Clinical Emergency
Send us Fan Mail After training as a physician, earning an MBA from Wharton, and co-founding Sonara Health, a digital health company that raised over $10…
- PETRI DISH PERSPECTIVES
September 2026: Biotech & Pharma NEWS Roundup
Send us Fan Mail Welcome to your essential overview of the global biotech and pharmaceutical landscape for September 2026! This month was defined by…
- PETRI DISH PERSPECTIVES
Episode 75: Hengrui
Send us Fan Mail In this episode of Petri Dish Perspectives, we explore Jiangsu Hengrui Pharmaceuticals, the Chinese pharma giant that started as a state-owned…
- PETRI DISH PERSPECTIVES
Episode 74: Dr. John Murphy on Building an Audience
Send us Fan Mail After years of running a school on the rigid rhythm of bells, Dr. John Murphy walked away from K-12 education and into something he never…
- PETRI DISH PERSPECTIVES
Episode 73: Anew Labs
Send us Fan Mail In this episode of Petri Dish Perspectives, we explore Anew Labs, the AI drug discovery company that emerged from one of the most unexpected…
- PETRI DISH PERSPECTIVES
Episode 72: Dr. Elliot Justin on S3xual Wearable Health Tech
Send us Fan Mail After a career spent racing against the clock in emergency rooms, Dr. Elliot Justin found himself chasing a very different kind of vital sign…
- PETRI DISH PERSPECTIVES
Episode 71: Fate of Pharma M&A
Send us Fan Mail In this episode of Petri Dish Perspectives, we take a step back from individual companies to examine one of the most powerful forces shaping…
- PETRI DISH PERSPECTIVES
August 2026: Biotech & Pharma NEWS Roundup
Send us Fan Mail Welcome to your essential overview of the global biotech and pharmaceutical landscape for August 2026! This month was defined by major…
- PETRI DISH PERSPECTIVES
Episode 70: Cellares
Send us Fan Mail In this episode of Petri Dish Perspectives, we explore Cellares, the biotech company trying to solve one of the biggest and least discussed…
- PETRI DISH PERSPECTIVES
Episode 69: Summit Therapeutics
Send us Fan Mail In this episode of Petri Dish Perspectives, we explore the remarkable rise of Summit Therapeutics, a biotech that transformed itself from an…
- PETRI DISH PERSPECTIVES
Episode 68: Guardant Health
Send us Fan Mail In this episode of Petri Dish Perspectives, we explore the story of Guardant Health, one of the companies leading the shift toward blood-based…
- PETRI DISH PERSPECTIVES
Episode 67: Epic Systems
Send us Fan Mail In this episode of Petri Dish Perspectives, we explore the story of Epic Systems, the privately held healthcare technology company that has…
- PETRI DISH PERSPECTIVES
July 2026: Biotech & Pharma NEWS Roundup
Send us Fan Mail Welcome to your essential overview of the global biotech and pharmaceutical landscape for June 2026! This month was dominated by AI cementing…
- PETRI DISH PERSPECTIVES
Episode 66: Scribe Therapeutics
Send us Fan Mail In this episode of Petri Dish Perspectives, we explore the story of Scribe Therapeutics, one of genome editing's most ambitious companies…
- PETRI DISH PERSPECTIVES
Episode 65: Apogee Therapeutics
Send us Fan Mail In this episode of Petri Dish Perspectives, we explore the story of Apogee Therapeutics, one of biotech's newest immunology companies aiming…
- PETRI DISH PERSPECTIVES
Episode 64: Conception Bio
Send us Fan Mail In this episode of Petri Dish Perspectives, we explore the story of Conception Bio, one of the most ambitious biotechnology companies working…
- PETRI DISH PERSPECTIVES
Episode 63: Enveda Biosciences
Send us Fan Mail In this episode of Petri Dish Perspectives, we explore the story of Enveda Biosciences, one of the most exciting AI-native biotech companies…
- PETRI DISH PERSPECTIVES
Episode 62: Isomorphic Labs
Send us Fan Mail In this episode of Petri Dish Perspectives, we explore the story of Isomorphic Labs, Alphabet's ambitious drug discovery company born out of…
- PETRI DISH PERSPECTIVES
June 2026: Biotech & Pharma NEWS Roundup
Send us Fan Mail Welcome to your essential overview of the global biotech and pharmaceutical landscape for June 2026! This month was dominated by a relentless…
- PETRI DISH PERSPECTIVES
Episode 61: Danaher
Send us Fan Mail In this episode of Petri Dish Perspectives, we explore how two brothers transformed a small industrial holding company into one of the most…
- PETRI DISH PERSPECTIVES
Episode 60: Hims & Hers
Send us Fan Mail In this episode of Petri Dish Perspectives, we dive into the rise of Hims & Hers Health, the telehealth company that transformed…
- PETRI DISH PERSPECTIVES
Episode 59: Illumina
Send us Fan Mail In this episode of Petri Dish Perspectives, we dive into the remarkable story of Illumina, from a small sequencing startup born during the…
- PETRI DISH PERSPECTIVES
Episode 58: UnitedHealthcare
Send us Fan Mail In this episode of Petri Dish Perspectives, we dive into the remarkable rise of UnitedHealthcare and its parent company, UnitedHealth Group…
- PETRI DISH PERSPECTIVES
May 2026: Biotech & Pharma NEWS Roundup
Send us Fan Mail Welcome to your essential overview of the global biotech and pharmaceutical landscape for May 2026! This month was dominated by a wave of…
- PETRI DISH PERSPECTIVES
Episode 57: 23andMe
Send us Fan Mail This week on Petri Dish Perspectives, we unpack the story of 23andMe, the company that turned saliva kits into one of the largest human…
- PETRI DISH PERSPECTIVES
Episode 56: Thermo Fisher
Send us Fan Mail This week on Petri Dish Perspectives, we’re diving into the story of Thermo Fisher Scientific, the company quietly powering nearly every…
- PETRI DISH PERSPECTIVES
Episode 55: Alnylam
Send us Fan Mail From the discovery of RNA interference to the first FDA-approved gene-silencing therapy, this week on Petri Dish Perspectives, we dive into…
- PETRI DISH PERSPECTIVES
Episode 54: All about 340B
Send us Fan Mail In this episode of Petri Dish Perspectives, we break down the 340B Drug Pricing Program, a little-known but massively influential policy…
- PETRI DISH PERSPECTIVES
April 2026: Biotech & Pharma NEWS Roundup
Send us Fan Mail Welcome to your essential overview of the global biotech and pharmaceutical landscape for April 2026! This month was dominated by a…
- PETRI DISH PERSPECTIVES
Episode 53: CAR-T Therapies
Send us Fan Mail What if cancer treatment wasn’t a drug but a living, evolving system inside your body? In this episode, we break down one of the most…
- PETRI DISH PERSPECTIVES
Episode 52: Daiichi Sankyo
Send us Fan Mail In this episode of Petri Dish Perspectives: Biotech Unleashed, we break down the rise of Daiichi Sankyo, a company that quietly transformed…
- PETRI DISH PERSPECTIVES
Episode 51: ImmunoGen
Send us Fan Mail In this episode of Petri Dish Perspectives: Biotech Unleashed, we dive into the 40+ year journey of ImmunoGen, a company that refused to give…
- PETRI DISH PERSPECTIVES
Episode 50: Exact Sciences
Send us Fan Mail In this episode of Petri Dish Perspectives, we’re dissecting the "Phoenix of Biotech." On March 23, 2026, the era of Exact Sciences as an…
- PETRI DISH PERSPECTIVES
Episode 49: AI in Pharma / Biotech
Send us Fan Mail In this episode, we explore the high-stakes reality of AI integration in the life sciences. We move past the speculative hype to examine the…
- PETRI DISH PERSPECTIVES
March 2026: Biotech & Pharma NEWS Roundup
Send us Fan Mail Welcome to your essential overview of the global biotech and pharmaceutical landscape for March 2026! This month was dominated by by three…
- PETRI DISH PERSPECTIVES
Episode 48: Ginkgo Bioworks
Send us Fan Mail In this episode of Petri Dish Perspectives, we unpack how Ginkgo Bioworks set out to industrialize biology. From its origins at MIT to…
- PETRI DISH PERSPECTIVES
Episode 47: SUN Pharma
Send us Fan Mail From a small operation built on just ₹10,000 to a global pharmaceutical powerhouse, Sun Pharmaceutical Industries is one of the most…
- PETRI DISH PERSPECTIVES
Episode 46: Servier
Send us Fan Mail In this episode of Petri Dish Perspectives, we explore the remarkable history of Servier, France’s largest independent pharmaceutical company…
- PETRI DISH PERSPECTIVES
Episode 45: BioMarin
Send us Fan Mail Most biotech companies chase massive markets. But BioMarin Pharmaceutical built its entire strategy around something very different…
- PETRI DISH PERSPECTIVES
February 2026: Biotech & Pharma NEWS Roundup
Send us Fan Mail Welcome to your essential overview of the global biotech and pharmaceutical landscape for February 2026! This month was dominated by by three…
- PETRI DISH PERSPECTIVES
Episode 44: BioNTech
Send us Fan Mail Before the world knew the power of mRNA vaccines, BioNTech was a relatively quiet biotech company focused on one ambitious goal: curing cancer…
- PETRI DISH PERSPECTIVES
Episode 43: ARCH Venture Partners
Send us Fan Mail In this episode of Petri Dish Perspectives, we unpack the strategy and scientific conviction behind ARCH Venture Partners, the venture firm…
- PETRI DISH PERSPECTIVES
Episode 42: Otsuka
Send us Fan Mail In this episode of Petri Dish Perspectives, we explore the fascinating evolution of Otsuka Holdings, a company that defies traditional…
- PETRI DISH PERSPECTIVES
Episode 41: Gene Therapies
Send us Fan Mail What if medicine could fix disease at its source… by rewriting the genetic code itself? In this episode of Petri Dish Perspectives, we dive…
- PETRI DISH PERSPECTIVES
January 2026: Biotech & Pharma NEWS Roundup
Send us Fan Mail Welcome to your essential overview of the global biotech and pharmaceutical landscape for January 2026! This month was dominated by a surge in…
- PETRI DISH PERSPECTIVES
Episode 40: Eisai
Send us Fan Mail What does it take to spend decades chasing one of medicine’s hardest problems while the rest of the industry walks away? In this episode, we…
- PETRI DISH PERSPECTIVES
Episode 39: Flagship Pioneering
Send us Fan Mail Flagship Pioneering doesn’t wait for scientific breakthroughs. It builds them. In this episode, we dive deep into the origin story of one of…
- PETRI DISH PERSPECTIVES
Episode 38: Biogen
Send us Fan Mail Biogen is one of the most influential and controversial companies in modern biotechnology. Founded in the late 1970s by Nobel-level scientists…
- PETRI DISH PERSPECTIVES
Episode 37: Theranos
Send us Fan Mail Theranos promised to revolutionize healthcare with a single drop of blood and became one of the most infamous failures in biotech history. In…
- PETRI DISH PERSPECTIVES
Episode 36: Novo Nordisk
Send us Fan Mail Novo Nordisk’s rise is one of the most extraordinary stories in modern medicine. What began in 1920s Denmark as a response to a fatal disease…
- PETRI DISH PERSPECTIVES
December 2025: Biotech & Pharma NEWS Roundup
Send us Fan Mail Welcome to your essential overview of the global biotech and pharmaceutical landscape for December 2025! This month was dominated by a surge…
- PETRI DISH PERSPECTIVES
Episode 35: Dyes to Pharma
Send us Fan Mail Before there were blockbuster drugs, clinical trials, and biotech startups, there was… dye. In this episode of Petri Dish Perspectives, we…
- PETRI DISH PERSPECTIVES
Episode 34: Astellas
Send us Fan Mail In this episode, we explore the evolution of Astellas Pharma, from the merger of two century-old Japanese firms into a global…
- PETRI DISH PERSPECTIVES
Episode 33: Novartis
Send us Fan Mail In this episode of Petri Dish Perspectives, we dive deep into the remarkable evolution of Novartis, one of the world’s most influential and…
- PETRI DISH PERSPECTIVES
Episode 32: Recursion
Send us Fan Mail Can a machine discover a cure faster than a scientist? Welcome to the revolutionary world of Recursion Pharmaceuticals, the pioneering TechBio…
- PETRI DISH PERSPECTIVES
November 2025: Biotech & Pharma NEWS Roundup
Send us Fan Mail Welcome to your essential overview of the global biotech and pharmaceutical landscape for November 2025! This month was dominated by a surge…
- PETRI DISH PERSPECTIVES
Episode 31: Bispecific Antibodies
Send us Fan Mail Unlock the future of immunotherapy. For decades, traditional antibody drugs were limited to tagging a single target. Now, meet the Bispecific…